1. Home
  2. BX vs SNY Comparison

BX vs SNY Comparison

Compare BX & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackstone Inc.

BX

Blackstone Inc.

HOLD

Current Price

$106.30

Market Cap

116.4B

Sector

Finance

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$43.50

Market Cap

116.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BX
SNY
Founded
1985
1994
Country
United States
France
Employees
N/A
74846
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.4B
116.8B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
BX
SNY
Price
$106.30
$43.50
Analyst Decision
Buy
Buy
Analyst Count
16
6
Target Price
$169.50
$61.50
AVG Volume (30 Days)
8.7M
4.2M
Earning Date
04-30-2026
01-01-0001
Dividend Yield
4.44%
3.66%
EPS Growth
6.91
N/A
EPS
3.87
N/A
Revenue
$14,450,265,000.00
N/A
Revenue This Year
$14.94
$3.01
Revenue Next Year
$21.75
$5.80
P/E Ratio
$26.32
$6.14
Revenue Growth
9.22
N/A
52 Week Low
$101.81
$43.51
52 Week High
$190.09
$59.17

Technical Indicators

Market Signals
Indicator
BX
SNY
Relative Strength Index (RSI) 33.15 31.35
Support Level $105.09 N/A
Resistance Level $165.14 $48.97
Average True Range (ATR) 4.63 0.69
MACD -0.13 -0.35
Stochastic Oscillator 25.29 2.66

Price Performance

Historical Comparison
BX
SNY

About BX Blackstone Inc.

Blackstone is the world's largest alternative-asset manager with $1.242 trillion in total asset under management, including $906.2 billion in fee-earning assets under management, at the end of September 2025. The company operates with scale in each of its major product lines: private equity (26% of fee-earning AUM and 33% of base management fees), real estate/real assets (31% and 35%), private credit (34% and 25%), and other alternatives (9% and 7%). While the firm primarily serves institutional investors (84% of AUM), it also caters to clients in the high-net-worth channel (16%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: